|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 11 studies with search of: | vicriviroc |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1) (Study P03672AM5)
|
||||
| 2 | Active, not recruiting |
Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Rollover Study for ACTG Protocol A5211 (Study P04100AM4)
|
||||
| 3 | Active, not recruiting |
Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241 AM3)
|
||||
| 4 | Terminated |
Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285)(TERMINATED)
|
||||
| 5 | Enrolling by invitation |
Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)
|
||||
| 6 | Active, not recruiting |
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM3)
|
||||
| 7 | Active, not recruiting |
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM6)
|
||||
| 8 | Active, not recruiting |
Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients
|
||||
| 9 | Active, not recruiting |
Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875AM3)
|
||||
| 10 | Active, not recruiting |
Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)
|
||||
| 11 | Recruiting |
Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and Adolescents
|